XTX Topco’s Avita Medical RCEL Stock Holding History

XTX Topco’s Portfolio RCEL Stock Details RCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-24,882	Closed	-$127K	–	3703
2025 Q3	$127K	Sell	24,882 -4,059	-14%	-$21.2K	0.01%	1965
2025 Q2	$153K	Buy	+28,941	New	+$211K	0.01%	1782

Other funds holding RCEL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

XTX Topco's RCEL Position: Q4 2025 in Review

XTX Topco sold out of Avita Medical (RCEL) in Q4 2025, closing a stake of 24,882 shares — an estimated $127K sold.

XTX Topco first reported a position in RCEL in Q2 2025 and held it in 2 quarters. The position peaked at $153K in Q2 2025. 67 funds tracked by Wall St. Rank hold RCEL as of Q4 2025.

XTX Topco reported no remaining Avita Medical position as of Q4 2025 after selling out during the quarter.
XTX Topco sold 24,882 Avita Medical shares in Q4 2025, an estimated $127K.
XTX Topco first reported a position in Avita Medical in Q2 2025 and held it in 2 quarters.
XTX Topco's Avita Medical position peaked at $153K in Q2 2025.
67 funds tracked by Wall St. Rank held Avita Medical as of Q4 2025.

Based on XTX Topco's 13F filing for Q4 2025, filed 17 Feb 2026.